Physical Address

304 North Cardinal St.
Dorchester Center, MA 02124

Category Science & Technology

ARPIs Beneficial in Prostate Cancer

TOPLINE: In patients with prostate cancer, androgen receptor pathway inhibitors (ARPIs) extended the median time to no longer clinically benefitting (NLCB) to 11.1 months vs the 6.9 months seen with taxanes. Overall survival was also higher for those taking ARPIs…

en_USEnglish